HOME >> MEDICINE >> NEWS
Cancer vaccine innovator honored with prestigious Florey Medal

Australian of the Year 2006, Professor Ian Frazer, will this evening follow in the footsteps of some of Australias greatest medical researchers, including Nobel Laureates Professor Barry Marshall and Professor Robin Warren, by being awarded the Merck Sharp & Dohme Florey Medal.

The prestigious honour is part of the Australian Institute of Policy and Sciences Tall Poppy Campaign and named after Australias first Nobel Laureate in Medicine, Sir Howard Florey, who made an indelible print on world health by developing penicillin.

The award comes as a clinical trial is about to get underway in Vanuatu to establish how effectively cervical cancer can be controlled in the developing world, where disease rates are higher than in the Western world, through use of appropriate screening technologies and deployment of the vaccine Professor Frazer created with his colleague, the late Dr Jian Zhou.

The study will also guide cervical cancer prevention strategies in resource poor settings and test the utility of delivering the vaccine to young children as part of a routine childhood immunisation schedule.

In addition, Professor Frazers research is now being developed by two Australian biotechnology companies to develop break-through approaches to treatment and prevention of Herpes and Hepatitis C.

Professor Rick McLean, Chair of the Tall Poppy Campaign and member of the Selection Committee for the Merck Sharp & Dohme Florey Medal, said the bi-annual accolade was created in 1998, the centenary of Sir Howard Floreys birth, to celebrate world standing achievements in biomedical science and human health advancement by Australian researchers.

"Around 20 top ranking scientists were in the running for this years medal. Professor Frazer was the clear winner reflecting the public health significance of the cervical cancer vaccine here and around the world," he said.

Professor McLean said the first winners of the Fl
'"/>

Contact: Jackie Crossman
040-221-8662
Research Australia
4-Mar-2007


Page: 1 2

Related medicine news :

1. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
2. Cancer research summaries
3. Cancer on the agenda of the Portuguese EU Council Presidency
4. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
5. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
6. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
7. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
8. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
9. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
10. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research
11. Cancer-fighting foods, supplements explored in day-long symposium, March 25

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... ... the first technology to directly address the resolution to globally reduce the harmful ... a patented compound of FDA and TTB approved ingredients that when infused into ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid Secret is a ... FASCP. The program was recently launched on March 1, and Dr. Wentz discussed ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... advancing the science and clinical practice of radiosurgery, announced today the publication ... multi-institutional, observational registry established to standardize data collection from patients treated with ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017 The global emerging cancer diagnostics market ... from 2016 to 2023 and reach a figure of ... is a chronic disease and is affecting a huge ... market. This report is focused on emerging cancer diagnostics ... is propelled due to factors such as: increasing number ...
(Date:3/28/2017)... 2017  Medeon Biodesign, Inc., a ... to announce that the Company led and successfully ... Inc., a San Jose, CA ... orthopedic extremity applications.  The orthopedic ... due to procedure volume growth, lifestyle influences and ...
(Date:3/28/2017)... -- "US Cancer Generics Market Outlook 2022" report gives ... analysis related to the emergence and integration of ... US. The report analyzes various clinical and non-clinical ... drugs in recent years. The introduction of generics ... for various stake holders involved US cancer drug ...
Breaking Medicine Technology:
Cached News: